Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Complaints To CDER Down, But Lorcaserin Weighs Heavily At Ombudsman's Office

Apr 11 2011

• By Martin Berman-Gorvine

Related Content

Panel Continues To Push For Obesity CV Guidance As It Backs <i>Contrave</i> Approval

Dec 13 2010

Qnexa May Get Staged Launch After No Vote From Advisory Committee

Jul 15 2010

Selective Trial Populations Weigh Against Advisory Panel Support For Lorqess

Sep 16 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window